Population I significantly decreased with MS duration within both, the CD4+ (R2 = 0.151, p = 0.026) and CD4+CD25+CD127loTreg gates (R2 = 0.16, p = 0.021) (data not shown). Here, CD4 is linked to myeloid sarcoma.